Inventor
ABDUL QUDDUS
Inventor
GB
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations44%
C07DHeterocyclic compounds44%
C07CAcyclic or carbocyclic compounds11%
PatentTitleYear
12,466,810N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases202512,371,419Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitors202511,987,573Aminopyrimidine/pyrazine derivatives as CTPS1 inhibitors202411,655,246Aminothiazole compounds as inhibitors of CTPS12023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to STEP PHARMA S A S (4)· patent assignee history
2023–2025Based in GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| STEP PHARMA S A S | 4 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 4 | 2023–2025 |